@xconomy.com 19 hours ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com 7 months ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com 8 months ago
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers